COMMUNIQUÉ RÉGLEMENTÉ publié le 15/01/2024 à 17:45, il y a 2 années 6 mois December 2023 ALTEN SA, a leading European company in Engineering and Technology Consulting, has disclosed the total number of outstanding shares and voting rights in accordance with the French Commercial code and AMF General Regulation. The company, listed on Euronext Paris, is involved in design and research projects for major clients in industry, telecoms, and services. Shareholders are reminded about the notification requirements for crossing the 3% threshold, as per ALTEN's Articles of Association. For more information, visit ALTEN's investor relations website or contact the designated journalists for media inquiries. Euronext Paris Voting Rights French Commercial Code ALTEN SA Engineering And Technology Consulting
COMMUNIQUÉ RÉGLEMENTÉ publié le 26/10/2023 à 17:40, il y a 2 années 8 mois ALTEN : activité à fin septembre 2023
COMMUNIQUÉ RÉGLEMENTÉ publié le 26/10/2023 à 17:40, il y a 2 années 8 mois ALTEN: business at the end of September 2023
Publié le 22/07/2026 à 18:19, il y a 2 heures 33 minutes Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Publié le 22/07/2026 à 18:19, il y a 2 heures 33 minutes Covivio successfully places €500 million of 7-year European Green Bonds
Publié le 22/07/2026 à 17:45, il y a 3 heures 7 minutes Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Publié le 22/07/2026 à 17:45, il y a 3 heures 7 minutes Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Publié le 22/07/2026 à 17:40, il y a 3 heures 12 minutes Report on share repurchases from 15 to 21 July 2026
Publié le 22/07/2026 à 15:00, il y a 5 heures 52 minutes Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Publié le 22/07/2026 à 15:00, il y a 5 heures 52 minutes Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Publié le 22/07/2026 à 14:35, il y a 6 heures 17 minutes Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Publié le 22/07/2026 à 14:30, il y a 6 heures 22 minutes As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Publié le 22/07/2026 à 20:44, il y a 8 minutes EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on July 22, 2026
Publié le 22/07/2026 à 20:08, il y a 44 minutes EQS-Adhoc: FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Publié le 22/07/2026 à 19:35, il y a 1 heure 17 minutes Stabilus SE: Invitation to a web conference on Q3 FY2026 results on August 3, 2026
Publié le 22/07/2026 à 19:29, il y a 1 heure 23 minutes EQS-Adhoc: Stabilus SE: Profit from operating activities and profit for the period significantly higher, adjusted FCF lower than in Q3 of the prior year; full-year forecast specified within the original ranges